apyrase and tryptamine

apyrase has been researched along with tryptamine* in 1 studies

Other Studies

1 other study(ies) available for apyrase and tryptamine

ArticleYear
Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship.
    Bioorganic chemistry, 2019, Volume: 82

    Overexpression of NTPDases leads to a number of pathological situations such as thrombosis, and cancer. Thus, effective inhibitors are required to combat these pathological situations. Different classes of NTPDase inhibitors are reported so far including nucleotides and their derivatives, sulfonated dyes such as reactive blue 2, suramin and its derivatives, and polyoxomatalates (POMs). Suramin is a well-known and potent NTPDase inhibitor, nonetheless, a range of side effects are also associated with it. Reactive blue 2 also had non-specific side effects that become apparent at high concentrations. In addition, most of the NTPDase inhibitors are high molecular weight compounds, always required tedious chemical steps to synthesize. Hence, there is still need to explore novel, low molecular weight, easy to synthesize, and potent NTPDase inhibitors. Keeping in mind the known NTPDase inhibitors with imine functionality and nitrogen heterocycles, Schiff bases of tryptamine, 1-26, were synthesized and characterized by spectroscopic techniques such as EI-MS, HREI-MS,

    Topics: Adenosine Triphosphatases; Animals; Antigens, CD; Apyrase; Catalytic Domain; Cell Line; Chlorocebus aethiops; Enzyme Inhibitors; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Schiff Bases; Structure-Activity Relationship; Tryptamines

2019